Minimal essential length of Clostridium botulinum C3 peptides to enhance neuronal regenerative growth and connectivity in a non-enzymatic mode

Journal of Neurochemistry

Volumn 120, Issue 6, 2012, Pages 1084-1096

  Loske, Peter ^a   Boato, Francesco ^b,d   Hendrix, Sven ^b   Piepgras, Johannes ^a   Just, Ingo ^c   Ahnert Hilger, Gudrun ^a   Höltje, Markus ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HASSELT UNIVERSITY   (Belgium)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d SORBONNE UNIVERSITÉ   (France)

Author keywords

C3 transferase; Regeneration; RhoA; Spinal cord injury

Indexed keywords

EXOENZYME C3; PEPTIDE DERIVATIVE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DENDRITE; DRUG EFFECT; DRUG EFFICACY; DRUG SCREENING; EMBRYO; ENZYME ACTIVITY; FETUS; HIPPOCAMPUS; IN VIVO STUDY; LOCOMOTION; MOTONEURON; MOUSE; NERVE CELL CULTURE; NERVE CELL GROWTH; NERVE FIBER GROWTH; NERVE REGENERATION; NONHUMAN; PRIORITY JOURNAL; REINNERVATION; SEROTONINERGIC TRANSMISSION; SPINAL CORD INJURY; UPREGULATION;

ADP RIBOSE TRANSFERASES; ANIMALS; ANIMALS, NEWBORN; BOTULINUM TOXINS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EMBRYO, MAMMALIAN; GABAERGIC NEURONS; GREEN FLUORESCENT PROTEINS; HIPPOCAMPUS; LOCOMOTION; MICE; MICE, INBRED BALB C; NEURONS; ORGAN CULTURE TECHNIQUES; PEPTIDES; RHO GTP-BINDING PROTEINS; SEROTONERGIC NEURONS; SEROTONIN; SPINAL CORD INJURIES; SPINAL CORD REGENERATION; SYNAPSES; TIME FACTORS; TRANSFECTION; VERSICANS; VESICULAR INHIBITORY AMINO ACID TRANSPORT PROTEINS;

CLOSTRIDIUM BOTULINUM; MUS;

EID: 84857921407     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2012.07657.x     Document Type: Article

References (42)

1. Ahnert-Hilger G., Höltje M., Grosse G., Pickert G., Mucke C., Nixdorf- Bergweiler B., Boquet P., Hofmann F. and Just I. (2004) Differential effects of Rho GTPases on axonal and dendritic development in hippocampal neurones. J. Neurochem. 90, 9-18. (Pubitemid 38879157)
2. Aktories K. and Just I. (2005) Clostridial Rho-inhibiting protein toxins. Curr. Top. Microbiol. Immunol. 291, 113-145. (Pubitemid 40674913)
3. Albertinazzi C., Gilardelli D., Paris S., Longhi R. and de Curtis I. (1998) Overexpression of a neural-specific rho family GTPase, cRac1B, selectively induces enhanced neuritogenesis and neurite branching in primary neurons. J. Cell Biol. 142, 815-825. (Pubitemid 28381497)
4. Basso D. M., Beattie M. S. and Bresnahan J. C. (1995) A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 12, 1-21.
5. Basso D. M., Fisher L. C., Anderson A. J., Jakeman L. B., McTigue D. M. and Popovich P. G. (2006) Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J. Neurotrauma 23, 635-659. (Pubitemid 43728052)
6. Bertrand J., Di Polo A. and McKerracher L. (2007) Enhanced survival and regeneration of antagonists. Neurobiol. Dis. 25, 65-72.
7. Boato F., Hendrix S., Huelsenbeck S. C. et al. (2010) C3 peptide enhances recovery from spinal cord injury by improved regenerative growth of descending fiber tracts. J. Cell Sci. 123, 1652-1662.
8. Boido M., Rupa R., Garbossa D., Fontanella M., Ducati A. and Vercelli A. (2009) Embryonic and adult stem cells promote raphespinal axon outgrowth and improve functional outcome following spinal hemisection in mice. Eur. J. Neurosci. 30, 833-846.
9. Chen H. and Firestein B. L. (2007) RhoA regulates dendrite branching in hippocampal neurons by decreasing cypin protein levels. J. Neurosci. 27, 8378-8386. (Pubitemid 47219610)
10. Conrad S., Schluesener H. J., Trautmann K., Joannin N., Meyermann R. and Schwab J. M. (2005) Prolonged lesional expression of RhoA and RhoB following spinal cord injury. J. Comp. Neurol. 487, 166-175. (Pubitemid 40734117)
11. Dergham P., Ellezam B., Essagian C., Avedissian H., Lubell W. D. and McKerracher L. (2002) Rho signaling pathway targeted to promote spinal cord repair. J. Neurosci. 22, 6570-6577. (Pubitemid 35386413)
12. Dubreuil C. I., Winton M. J. and McKerracher L. (2003) Rho activation patterns after spinal cord injury and the role of activated Rho in apoptosis in the central nervous system. J. Cell Biol. 162, 233-243. (Pubitemid 36928837)
13. Hall A. and Lalli G. (2010) Rho and Ras GTPases in axon growth, guidance, and branching. Cold Spring Harb. Perspect. Biol. 2, a001818.
14. Han S., Arvai A. S., Clancy S. B. and Tainer J. A. (2001) Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis. J. Mol. Biol. 305, 95-107. (Pubitemid 32039748)
15. Harvey P. J., Li X., Li Y. and Bennett D. J. (2006) 5-HT2 receptor activation facilitates a persistent sodium current and repetitive firing in spinal motoneurons of rats with and without chronic spinal cord injury. J. Neurophysiol. 96, 1158-1170. (Pubitemid 44371511)
16. Hechler D., Nitsch R. and Hendrix S. (2006) Green-fluorescent-protein- expressing mice as models for the study of axonal growth and regeneration in vitro. Brain Res. Rev. 52, 160-169. (Pubitemid 44051535)
17. Hechler D., Boato F., Nitsch R. and Hendrix S. (2010) Differential regulation of axon outgrowth and reinnervation by neurotrophin-3 and neurotrophin-4 in the hippocampal formation. Exp. Brain Res. 205, 215-221.
18. Henneberger C., Jüttner R., Schmidt S. A., Walter J., Meier J. C., Rothe T. and Grantyn R. (2005) GluR- and TrkB-mediated maturation of GABA receptor function during the period of eye opening. Eur. J. Neurosci. 2, 431-440. (Pubitemid 40204246)
19. Höltje M., Djalali S., Hofmann F. et al. (2009) A 29-amino acid fragment of Clostridium botulinum C3 protein enhances neuronal outgrowth, connectivity, and reinnervation. FASEB J. 23, 1115-1126.
20. Jin Z. and Strittmatter S. M. (1997) Rac1 mediates collapsin-1-induced growth cone collapse. J. Neurosci. 17, 6256-6263. (Pubitemid 27329900)
21. Just I., Rohrbeck A., Huelsenbeck S. C. and Hoeltje M. (2011) Therapeutic effects of Clostridium botulinum C3 exoenzyme. Naunyn Schmiedebergs Arch. Pharmacol. 383, 247-252.
22. Kakimoto T., Katoh H. and Negishi M. (2006) Regulation of neuronal morphology by Toca-1, an F-BAR/EFC protein that induces plasma membrane invagination. J. Biol. Chem. 281, 29042-29053. (Pubitemid 44507048)
23. Kalil K., Szebenyi G. and Dent E. W. (2000) Common mechanisms underlying growth cone guidance and axon branching. J. Neurobiol. 44, 145-158.
24. Lehmann M., Fournier A., Selles-Navarro I., Dergham P., Sebok A., Leclerc N., Tigyi G. and McKerracher L. (1999) Inactivation of Rho signaling pathway promotes CNS axon regeneration. J. Neurosci. 19, 7537-7547. (Pubitemid 29404610)
25. Li X., Murray K., Harvey P. J., Ballou E. W. and Bennett D. J. (2007) Serotonin facilitates a persistent calcium current in motoneurons of rats with and without chronic spinal cord injury. J. Neurophysiol. 97, 1236-1246. (Pubitemid 46239501)
26. McKerracher L. and Higuchi H. (2006) Targeting Rho to stimulate repair after spinal cord injury. J. Neurotrauma 23, 309-317. (Pubitemid 43726312)
27. Ménétrey J., Flatau G., Boquet P., Ménez A. and Stura E. A. (2008) Structural basis for the NAD-hydrolysis mechanism and the ARTT-loop plasticity of C3 exoenzymes. Protein Sci. 17, 878-886. (Pubitemid 351629582)
28. Müllner A., Gonzenbach R. R., Weinmann O., Schnell L., Liebscher T. and Schwab M. E. (2008) Lamina-specific restoration of serotonergic projections after Nogo-A antibody treatment of spinal cord injury in rats. Eur. J. Neurosci. 27, 326-333.
29. Murray K. C., Nakae A., Stephens M. J. et al. (2010) Recovery of motoneuron and locomotor function after spinal cord injury depends on constitutive activity in 5-HT2C receptors. Nat. Med. 16, 694-700.
30. Rekling J. C., Funk G. D., Bayliss D. A., Dong X. W. and Feldman J. L. (2000) Synaptic control of motoneuronal excitability. Physiol. Rev. 80, 767-852. (Pubitemid 30164949)
31. Schmitt K. R., Kern C., Lange P. E., Berger F., Abdul-Khaliq H. and Hendrix S. (2007) S100B modulates IL-6 release and cytotoxicity from hypothermic brain cells and inhibits hypothermia-induced axonal outgrowth. Neurosci. Res. 59, 68-73. (Pubitemid 47285395)
32. Schmitt K. R., Boato F., Diestel A., Hechler D., Kruglov A., Berger F. and Hendrix S. (2010) Hypothermia-induced neurite outgrowth is mediated by tumor necrosis factor-alpha. Brain Pathol. 20, 771-779.
33. Schweigreiter R., Walmsley A. R., Niederöst B., Zimmermann D. R., Oertle T., Casademunt E., Frentzel S., Dechant G., Mir A. and Bandtlow C. E. (2004) Versican V2 and the central inhibitory domain of Nogo-A inhibit neurite growth via p75NTR/NgR-independent pathways that converge at RhoA. Mol. Cell. Neurosci. 27, 163-174. (Pubitemid 39370098)
34. Sekhon L. H. and Fehlings M. G. (2001) Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine 26(24 Suppl.) 2-12.
35. Shen Y., Tenney A. P., Busch S. A., Horn K. P., Cuascut F. X., Liu K., He Z., Silver J. and Flanagan J. G. (2009) PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration. Science 326(5952), 592-596.
36. Sheng H., Wang H., Homi H. M., Spasojevic I., Batinic-Haberle I., Pearlstein R. D. and Warner D. S. (2004) A no-laminectomy spinal cord compression injury model in mice. J. Neurotrauma 21, 595-603. (Pubitemid 38656756)
37. Sieber-Blum M., Schnell L., Grim M., Hu Y. F., Schneider R. and Schwab M. E. (2006) Characterization of epidermal neural crest stem cell (EPI-NCSC) grafts in the lesioned spinal cord. Mol. Cell. Neurosci. 32, 67-81. (Pubitemid 43868097)
38. Simonen M., Pedersen V., Weinmann O., Schnell L., Buss A., Ledermann B., Christ F., Sansig G., van der. Putten. H. and Schwab M. E. (2003) Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron 38, 201-211. (Pubitemid 36555647)
39. Ung R. V., Landry E. S., Rouleau P., Lapointe N. P., Rouillard C. and Guertin P. A. (2008) Role of spinal 5-HT2 receptor subtypes in quipazine-induced hindlimb movements after a low-thoracic spinal cord transection. Eur. J. Neurosci. 28, 2231-2242.
40. Vogelsgesang M., Pautsch A. and Aktories K. (2007) C3 exoenzymes, novel insights into structure and action of Rho-ADP-ribosylating toxins. Naunyn Schmiedebergs Arch. Pharmacol. 374, 347-360. (Pubitemid 46215285)
41. Wilde C., Barth H., Sehr P., Han L., Schmidt M., Just I. and Aktories K. (2002) Interaction of the Rho-ADP-ribosylating C3 exoenzyme with RalA. J. Biol. Chem. 277, 14771-14776. (Pubitemid 34952549)
42. Yamashita T. and Tohyama M. (2003) The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI. Nat. Neurosci. 6, 461-467. (Pubitemid 36514693)